AGE DEPENDENT FACTORS IN URETERAL/VESICAL FUNCTION

输尿管/膀胱功能的年龄依赖性因素

基本信息

  • 批准号:
    2518275
  • 负责人:
  • 金额:
    $ 30.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1977
  • 资助国家:
    美国
  • 起止时间:
    1977-02-01 至 1999-06-30
  • 项目状态:
    已结题

项目摘要

Age-dependent abnormalities in the function of urinary tract smooth muscle may lead to deterioration in renal structure and function and/or may result in incontinence with its resultant medical, psychological, sociological, and economic implications. These functional changes may result from alterations in regulatory mechanisms or from changes in membrane structure or composition. The unifying hypothesis of this proposal is that aging causes changes in the biochemical and functional properties of urinary tract smooth muscle, and that these changes may in turn influence the response of these tissues to pharmacologic manipulation and pathologic insult. The long-term objective is to determine both how and why age affects the function of urinary tract smooth muscle. To achieve this goal, we will study changes in ureteral-vesical function with age at the level of 1) signal recognition (hormone-receptor complex); 2) signal transmission (transduction of the signal generated by the interaction of an agonist or hormone with a receptor from the outside of the plasma membrane to the inside of the cell where a biochemical and ultimately a physiologic event occurs); and 3) signal functional response (response to the transmitted signal as measured by changes in contractile force). We plan to: 1) define the physiological parameters involved in receptor regulation, i.e., the regulatory effects of gonadal hormones on the receptor-effector system, 2) characterize and localize autonomic and calcium antagonist receptor subtypes 3) determine the regulatory effect of G-proteins in the transduction of the hormone-receptor signal in adrenergic, muscarinic cholinergic, and calcium antagonist receptor systems, 4) determine how changes in membrane structure and composition that occur with aging affect the functional response of urinary tract smooth muscle, 5) determine the role of the second messengers, i.e., cyclic AMP, cyclic GMP, Ca++ and the products of inositol phospholipid metabolism (inositol trisphosphate, IP3, and diacylglycerol, DG) in the age-dependent functional changes of urinary tract smooth muscle, and 6) determine how age-dependent changes in signal recognition and signal transmission affect the functional response to Ca++ and its agonists and antagonists, membrane perturbers, and potassium channel agonists and antagonists. The determination of how age affects the function of urinary tract smooth muscle and the response of the smooth muscle to pharmacologic agents may provide a rationale for the development of new drugs for the treatment of pathologic states.
Age-dependent abnormalities in the function of urinary tract smooth muscle may lead to deterioration in renal structure and function and/or may result in incontinence with its resultant medical, psychological, sociological, and economic implications. These functional changes may result from alterations in regulatory mechanisms or from changes in membrane structure or composition. The unifying hypothesis of this proposal is that aging causes changes in the biochemical and functional properties of urinary tract smooth muscle, and that these changes may in turn influence the response of these tissues to pharmacologic manipulation and pathologic insult. The long-term objective is to determine both how and why age affects the function of urinary tract smooth muscle. To achieve this goal, we will study changes in ureteral-vesical function with age at the level of 1) signal recognition (hormone-receptor complex); 2) signal transmission (transduction of the signal generated by the interaction of an agonist or hormone with a receptor from the outside of the plasma membrane to the inside of the cell where a biochemical and ultimately a physiologic event occurs); and 3) signal functional response (response to the transmitted signal as measured by changes in contractile force). We plan to: 1) define the physiological parameters involved in receptor regulation, i.e., the regulatory effects of gonadal hormones on the receptor-effector system, 2) characterize and localize autonomic and calcium antagonist receptor subtypes 3) determine the regulatory effect of G-proteins in the transduction of the hormone-receptor signal in adrenergic, muscarinic cholinergic, and calcium antagonist receptor systems, 4) determine how changes in membrane structure and composition that occur with aging affect the functional response of urinary tract smooth muscle, 5) determine the role of the second messengers, i.e., cyclic AMP, cyclic GMP, Ca++ and the products of inositol phospholipid metabolism (inositol trisphosphate, IP3, and diacylglycerol, DG) in the age-dependent functional changes of urinary tract smooth muscle, and 6) determine how age-dependent changes in signal recognition and signal transmission affect the functional response to Ca++ and its agonists and antagonists, membrane perturbers, and potassium channel agonists and antagonists. The determination of how age affects the function of urinary tract smooth muscle and the response of the smooth muscle to pharmacologic agents may provide a rationale for the development of new drugs for the treatment of pathologic states.

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neurokinin induced inositol phosphate production in guinea pig bladder.
神经激肽诱导豚鼠膀胱中磷酸肌醇的产生。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Martin,TV;Wheeler,MA;Weiss,RM
  • 通讯作者:
    Weiss,RM
Alterations in G-proteins and beta-adrenergic responsive adenylyl cyclase in rat urinary bladder during aging.
衰老过程中大鼠膀胱中 G 蛋白和 β-肾上腺素能反应性腺苷酸环化酶的变化。
Ontogeny of cyclic AMP and cyclic GMP phosphodiesterase activities and of calmodulin levels in guinea pig ureter.
豚鼠输尿管中环 AMP 和环 GMP 磷酸二酯酶活性以及钙调蛋白水平的个体发育。
  • DOI:
    10.1016/s0022-5347(17)42794-7
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Cho,YH;Wheeler,MA;Weiss,RM
  • 通讯作者:
    Weiss,RM
Nitric oxide synthase: an endogenous source of elevated nitrite in infected urine.
一氧化氮合酶:受感染尿液中亚硝酸盐升高的内源性来源。
  • DOI:
    10.1038/ki.1994.76
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    19.6
  • 作者:
    Smith,SD;Wheeler,MA;Weiss,RM
  • 通讯作者:
    Weiss,RM
Age dependence of adenylate cyclase in guinea pig ureter homogenate.
豚鼠输尿管匀浆中腺苷酸环化酶的年龄依赖性。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT M WEISS其他文献

ROBERT M WEISS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT M WEISS', 18)}}的其他基金

Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
  • 批准号:
    10216324
  • 财政年份:
    2018
  • 资助金额:
    $ 30.4万
  • 项目类别:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
  • 批准号:
    10452547
  • 财政年份:
    2018
  • 资助金额:
    $ 30.4万
  • 项目类别:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
  • 批准号:
    9977238
  • 财政年份:
    2018
  • 资助金额:
    $ 30.4万
  • 项目类别:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
钙化性主动脉瓣疾病损伤的传播和消退
  • 批准号:
    9762207
  • 财政年份:
    2018
  • 资助金额:
    $ 30.4万
  • 项目类别:
High-Resolution Research Ultrasound
高分辨率研究超声
  • 批准号:
    8824742
  • 财政年份:
    2015
  • 资助金额:
    $ 30.4万
  • 项目类别:
Research Ultrasound Imaging Upgrades
研究超声成像升级
  • 批准号:
    7784169
  • 财政年份:
    2010
  • 资助金额:
    $ 30.4万
  • 项目类别:
Targeted siRNA nanotechnology for intravesical treatment of urologicaldiseases
靶向 siRNA 纳米技术用于膀胱内治疗泌尿系统疾病
  • 批准号:
    7938678
  • 财政年份:
    2009
  • 资助金额:
    $ 30.4万
  • 项目类别:
Targeted siRNA nanotechnology for intravesical treatment of urologicaldiseases
靶向 siRNA 纳米技术用于膀胱内治疗泌尿系统疾病
  • 批准号:
    7832079
  • 财政年份:
    2009
  • 资助金额:
    $ 30.4万
  • 项目类别:
Encapsulated siRNAs for treatment of urological disease
用于治疗泌尿系统疾病的封装 siRNA
  • 批准号:
    7481032
  • 财政年份:
    2007
  • 资助金额:
    $ 30.4万
  • 项目类别:
Encapsulated siRNAs for treatment of urological disease
用于治疗泌尿系统疾病的封装 siRNA
  • 批准号:
    7238990
  • 财政年份:
    2007
  • 资助金额:
    $ 30.4万
  • 项目类别:

相似海外基金

Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
  • 批准号:
    RGPIN-2021-04040
  • 财政年份:
    2022
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Discovery Grants Program - Individual
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
  • 批准号:
    547124-2020
  • 财政年份:
    2022
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
  • 批准号:
    547124-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
  • 批准号:
    RGPIN-2021-04040
  • 财政年份:
    2021
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Discovery Grants Program - Individual
The Molecular Mechanism of the Secretion of the Bacterial Toxin Adenylate Cyclase
细菌毒素腺苷酸环化酶分泌的分子机制
  • 批准号:
    451966
  • 财政年份:
    2021
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Operating Grants
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10455587
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10261394
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
Diagnosis and therapeutic effect of neurally mediated syncope (NMS) using fluctuation of adenylate cyclase activity
利用腺苷酸环化酶活性波动对神经介导性晕厥(NMS)的诊断和治疗效果
  • 批准号:
    20K08498
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pituitary adenylate cyclase-activating polypeptide 27 in the paraventricular thalamus and its projections: Role in ethanol drinking
室旁丘脑中的垂体腺苷酸环化酶激活多肽 27 及其预测:在乙醇饮用中的作用
  • 批准号:
    10380126
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10662279
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了